Personalized therapeutic delivery in the neurosurgical operating room
- PMID: 30127023
- PMCID: PMC6130357
- DOI: 10.1073/pnas.1812559115
Personalized therapeutic delivery in the neurosurgical operating room
Conflict of interest statement
Conflict of interest statement: M.A.V. has patent and royalty interests in a drug delivery device and is the cofounder of Infuseon Therapeutics, for which he has indirect equity and royalty interests.
Comment on
-
Genotype-targeted local therapy of glioma.Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8388-E8394. doi: 10.1073/pnas.1805751115. Epub 2018 Aug 6. Proc Natl Acad Sci U S A. 2018. PMID: 30082399 Free PMC article.
References
-
- Louis DN, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131:803–820. - PubMed
-
- Alexander BM, Cloughesy TF. Adult glioblastoma. J Clin Oncol. 2017;35:2402–2409. - PubMed
-
- Friedman HS, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009;27:4733–4740. - PubMed
-
- Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15:422–442. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
